Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Vasopressin for Cooperative Behavior in Schizophrenia
NCT04190004Completed
- Sponsor
- National Institute of Mental Health and Neurosciences
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia comparing Vasopressin with Placebo (2 arms). Primary endpoints: Performance in Dictator game at 60 minutes and Performance in stag hunt game at 60 minutes. Started Jan 2018; status: completed.
02
Drugs
vasopressin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04190004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04190004.